Given the pivotal role that CYP26A1 plays in controlling retinoid metabolism and RA signaling, our understanding of how dysregulated CYP26A1 expression contributes to tumorigenesis should help us to develop new CYP26A1-based therapeutic strategies to target CSCs in CRC. Here, CYP26A1 is linked to colorectal carcinoma.